Association of wound, ischemia, and foot infection clinical stage with frailty and malnutrition in chronic limb-threatening ischemia patients undergoing endovascular intervention.


Journal

Vascular
ISSN: 1708-539X
Titre abrégé: Vascular
Pays: England
ID NLM: 101196722

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 1 6 2023
pubmed: 1 3 2022
entrez: 28 2 2022
Statut: ppublish

Résumé

The Wound, Ischemia, and foot Infection (WIfI) clinical stage has been thought to have a prognostic value in Chronic limb-threatening ischemia (CLTI) patients, and frailty and nutritional status appear to represent pivotal factor affecting prognosis among CLTI patients. The purpose of this study was to examine clinical factors (including frailty and nutritional status) relevant to WIfI clinical stage. This retrospective study investigated 200 consecutive CLTI patients. We individually assessed WIfI clinical stage, frailty according to the Clinical Frailty Scale (CFS) score, and malnutrition according to Geriatric Nutritional Risk Index (GNRI). We then compared mortality after endovascular intervention between a WIfI stage 1, 2 group and a stage 3, 4 group, and investigated associations between baseline characteristics (including CFS and GNRI) and WIfI clinical stage. Among 200 patients, 123 patients (62%) showed WIfI stage 1 or 2, and the remaining 77 patients (38%) had WIfI stage 3 or 4. CFS score was significantly higher in the WIfI stage 3, 4 group [median 6.0, interquartile range (IQR) 5.5-7.0] compared with the WIfI stage 1, 2 group (median 5.0, IQR 4.0-6.0, These results indicate that CLTI patients with high WIfI clinical stage may be more frail and malnourished, and be associated with poor prognosis after endovascular intervention.

Identifiants

pubmed: 35226573
doi: 10.1177/17085381221076943
pmc: PMC10233507
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

504-512

Références

J Atheroscler Thromb. 2021 May 1;28(5):477-482
pubmed: 32713933
Eur Heart J. 2018 Mar 1;39(9):763-816
pubmed: 28886620
J Vasc Surg. 2016 Jul;64(1):95-103
pubmed: 26994958
Circ Cardiovasc Interv. 2018 Jul;11(7):e006778
pubmed: 30006333
Am J Clin Nutr. 2008 Jan;87(1):150-5
pubmed: 18175749
J Vasc Surg. 2018 Oct;68(4):1104-1113.e1
pubmed: 29802042
J Vasc Surg. 2017 Mar;65(3):695-704
pubmed: 28073665
Circ Cardiovasc Interv. 2019 Dec;12(12):e008015
pubmed: 31771341
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Ageing Res Rev. 2017 May;35:63-73
pubmed: 28143778
Am J Clin Nutr. 2005 Oct;82(4):777-83
pubmed: 16210706
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40
pubmed: 31159978
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
J Vasc Surg. 2014 Jan;59(1):220-34.e1-2
pubmed: 24126108
Lancet Glob Health. 2019 Aug;7(8):e1020-e1030
pubmed: 31303293
Circulation. 2000 Aug 29;102(9):1014-9
pubmed: 10961966
Clin Res Cardiol. 2017 Jul;106(7):533-541
pubmed: 28204965
J Vasc Surg. 2015 Dec;62(6):1642-51.e3
pubmed: 26391460
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Eur J Vasc Endovasc Surg. 2016 Aug;52(2):218-24
pubmed: 27357968
J Atheroscler Thromb. 2020 Feb 1;27(2):134-143
pubmed: 31217396
Diabetes. 2004 Aug;53(8):2095-100
pubmed: 15277391
Circulation. 2005 Jul 5;112(1):25-31
pubmed: 15983251
Ann Vasc Surg. 2018 Jul;50:38-45
pubmed: 29477684
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2322-2331
pubmed: 32698688
JACC Cardiovasc Interv. 2014 Dec;7(12):1444-9
pubmed: 25523536
Circ J. 2018 May 25;82(6):1614-1622
pubmed: 29212959
Diabetes Care. 1999 Jun;22(6):951-9
pubmed: 10372248

Auteurs

Hideaki Otsuji (H)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Daisuke Kanda (D)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Takuro Takumi (T)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Akihiro Tokushige (A)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Takeshi Sonoda (T)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Ryo Arikawa (R)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Kazuhiro Anzaki (K)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Yoshiyuki Ikeda (Y)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Mitsuru Ohishi (M)

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH